000 01179 a2200337 4500
005 20250518080100.0
264 0 _c20200618
008 202006s 0 0 eng d
022 _a1523-1755
024 7 _a10.1016/j.kint.2019.08.039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeón-Jiménez, David
245 0 0 _aIs the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?
_h[electronic resource]
260 _bKidney international
_c01 2020
300 _a213 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBenzhydryl Compounds
650 0 4 _aDiabetes Mellitus, Type 2
650 0 4 _aDiabetic Nephropathies
650 0 4 _aDiuretics
650 0 4 _aGlucosides
650 0 4 _aHemodynamics
650 0 4 _aHumans
650 0 4 _aRenal Insufficiency, Chronic
650 0 4 _aSodium-Glucose Transporter 2 Inhibitors
700 1 _aMoreno-Obregón, Fernando
700 1 _aBeltrán-Romero, Luis M
700 1 _aMiramontes-González, José Pablo
773 0 _tKidney international
_gvol. 97
_gno. 1
_gp. 213
856 4 0 _uhttps://doi.org/10.1016/j.kint.2019.08.039
_zAvailable from publisher's website
999 _c30483294
_d30483294